ALUR.WS icon

Allurion Technologies Warrants

0.0301 USD
-0.0032
9.61%
At close May 15, 4:00 PM EDT
1 day
-9.61%
5 days
-7.38%
1 month
-3.83%
3 months
-29.84%
6 months
-45.27%
Year to date
-13.75%
1 year
-84.22%
5 years
-97.11%
10 years
-97.11%
 

About: Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.

Employees: 137

0
Funds holding %
of 7,425 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

76% more capital invested

Capital invested by funds: $341K [Q3] → $601K (+$261K) [Q4]

9.03% less ownership

Funds ownership: 15.37% [Q3] → 6.35% (-9.03%) [Q4]

14% less funds holding

Funds holding: 44 [Q3] → 38 (-6) [Q4]

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Research analyst outlook

We haven’t received any recent analyst ratings for ALUR.WS.

Financial journalist opinion

We haven’t received any recent news articles for ALUR.WS.

Charts implemented using Lightweight Charts™